61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Merck & Co Inc.
Open
Sector Healthcare
100.08 0.52
Overview
Share price change
24h
Min
99.6
Max
100.73
Income | -2.3B 3.2B |
|---|---|
Sales | 550M 17B |
P/E Sector Avg | 137.56 59.974 |
EPS | 1.57 |
Dividend yield | 2.712 |
Profit margin | 18.95 |
EBITDA | -1.4B 6.1B |
Recommendations | Buy |
|---|---|
12 Months Forecast | +24.58 upside |
Dividend yield Sector Avg | 2.71% 2.29% |
|---|---|
Next Earnings | 4 Feb 2025 |
Next Dividend date | 4 Apr 2025 |
Next Ex Dividend date | 13 Mar 2025 |
Market Cap | 1.9B 253B |
|---|---|
Previous open | 99.56 |
Previous close | 100.08 |
News Sentiment
By Acuity
42%
58%
156 / 392 Healthcare
Technical Score
By Trading Central
Confidence
Very Strong Bullish Evidence
Merck & Co Inc. Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Merck & Co Inc. Forecast
Price Target
By TipRanks
24.58% upside
12 Months Forecast
Average 124.14 USD 24.58%
High 150 USD
Low 105 USD
Based on 17 Wall Street analysts offering 12 month price targets forMerck & Co Inc. - Dist in the last 3 months.
Sentiment
By Acuity
156 / 392 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Merck & Co Inc.
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.
